FIELD: medicine.
SUBSTANCE: invention may be used for differential diagnostic of bronchial asthma (BA). Substance of the technique: a level of activity of effector caspase-3 of lymphocytes of peripheral venous blood is determined. If the level of activity of effector caspase-3 is no more than 0.98%, allergic BA is diagnosed, while the level of activity of effector caspase-3 is not less than 1.00%, non-allergic BA is diagnosed.
EFFECT: technique is described by simplicity, safety and adequate information value.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIFFERENTIAL DIAGNOSTICS OF BRONCHIAL ASTHMA | 2008 |
|
RU2391663C1 |
| METHOD FOR DISCRIMINATING BRONCHIAL ALLERGY | 1991 |
|
RU2023267C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR BRONCHIAL ASTHMA AND CHRONIC OBSTRUCTIVE PULMONARY DISEASE | 2012 |
|
RU2488830C1 |
| MEANS OF DIFFERENTIAL DIAGNOSTICS OF BRONCHIAL ASTHMA CLINICO-PATHOGENETIC VARIANTS AND INCIPIENCE OF CHRONIC OBSTRUCTIVE LUNG DISEASE | 2009 |
|
RU2442532C2 |
| METHOD FOR DIAGNOSTICS OF STEROID- RESISTANCE IN PATIENTS WITH BRONCHIAL ASTHMA | 2002 |
|
RU2201594C1 |
| DIFFERENTIAL DIAGNOSTIC TECHNIQUE FOR BRONCHIAL ASTHMA | 2012 |
|
RU2497117C2 |
| METHOD FOR DIAGNOSING ALLERGIC BRONCHIAL ASTHMA | 2021 |
|
RU2780687C1 |
| DIAGNOSTIC TECHNIQUE FOR METABOLIC COMPENSATION DISTURBANCES AND METHOD FOR PREDICTION OF RISK OF DEVELOPING IN PATIENTS WIT TYPE 2 DIABETES MELLITUS BY LYMPHOCYTE APOPTOSIS ASSESSMENT | 2011 |
|
RU2452965C1 |
| METHOD OF DIFFERENTIAL DIAGNOSIS OF ATOPIC AND INFECTION-DEPENDENT FORMS OF BRONCHIAL ASTHMA | 0 |
|
SU1767422A1 |
| METHOD FOR DETERMINING SEVERITY IN PATIENTS WITH BRONCHOPULMONARY DISEASES | 2010 |
|
RU2456598C2 |
